TITLE

European stem cell research in legal shackles

AUTHOR(S)
Nielen, Myrthe G; de Vries, Sybe A; Geijsen, Niels
PUB. DATE
December 2013
SOURCE
EMBO Journal;12/11/2013, Vol. 32 Issue 24, p3107
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Advances in stem cell biology have raised legal challenges to the patentability of stem cells and any derived technologies and processes. In 1999, Oliver Brüstle was granted a patent for the generation and therapeutic use of neural cells derived from human embryonic stem cells (hESCs). The patent was challenged and put before the European Court of Justice, which ruled that inventions involving the prior destruction of human embryos cannot be patented. The legal maneuvering around this case demonstrates that the future of stem cell-based patents in Europe remains unsettled. Furthermore, owing to the European Court's broad definition of hESC as 'any cell that is capable of commencing development into a human being,' novel technologies that could eliminate the need for hESCs, such as induced pluripotent stem cells (iPSCs), are at risk of being included under the same ruling. Advances in the in vitro development of germ cells from pluripotent stem cells may one day provide a direct developmental path from iPSC to oocyte and sperm, and, according to the European Court's reasoning, legally equate iPSCs with human embryos. In this review, we will briefly discuss the Brüstle v Greenpeace case and the implications of the European Court of Justice's ruling. We will identify potential risks for stem cell research and future therapeutics resulting from the broad legal definition of the human embryo. Finally, we will broach the current legal landscape, as this broad definition has also created great uncertainty about the status of human iPSCs.
ACCESSION #
92865644

 

Related Articles

  • Stem Cell Mutations Explored. Luntz, Stephen // Australasian Science;Mar2012, Vol. 33 Issue 2, p5 

    The article discusses a research study on pluripotent stem cells which found that there are higher mutation rates in the induced pluripotent stem cell (iPS) lines as compared with the human embryonic stem (HES) cell lines.

  • Pushing the Reset Button: Chemical-Induced Conversion of Amniotic Fluid Stem Cells Into a Pluripotent State. Diecke, Sebastian; Wu, Joseph C // Molecular Therapy;Oct2012, Vol. 20 Issue 10, p1839 

    The authors discuss the study on the factor-free derivation of a pluripotent cell type using a c-Kit+ subpopulation of human amniotic fluid cells. The authors say that the potential of human embryonic stem cells (hESC) to differentiate into any cell type of the human body has raised the hope on...

  • PRMT5 is Required for Human Embryonic Stem Cell Proliferation But Not Pluripotency. Gkountela, Sofia; Li, Ziwei; Chin, Chee; Lee, Serena; Clark, Amander // Stem Cell Reviews & Reports;Apr2014, Vol. 10 Issue 2, p230 

    Human pluripotent stem cells (PSCs) are critical in vitro tools for understanding mechanisms that regulate lineage differentiation in the human embryo as well as a potentially unlimited supply of stem cells for regenerative medicine. Pluripotent human and mouse embryonic stem cells (ESCs)...

  • PIEZO2 is required for mechanotransduction in human stem cell-derived touch receptors. Schrenk-Siemens, Katrin; Wende, Hagen; Prato, Vincenzo; Song, Kun; Rostock, Charlotte; Loewer, Alexander; Utikal, Jochen; Lewin, Gary R; Lechner, Stefan G; Siemens, Jan // Nature Neuroscience;Jan2015, Vol. 18 Issue 1, p10 

    Human sensory neurons are inaccessible for functional examination, and thus little is known about the mechanisms mediating touch sensation in humans. Here we demonstrate that the mechanosensitivity of human embryonic stem (hES) cell-derived touch receptors depends on PIEZO2. To recapitulate...

  • The Law and Politics of Embryo Research in America. Carter Snead, O. // Human Reproduction & Genetic Ethics;2011, Vol. 17 Issue 1, p40 

    The moral, legal, and public policy dispute over embryonic stem cell research (and related matters, such as human cloning) is the most prominent issue in American public bioethics of the past decade. The primary moral question raised by the practice of embryonic stem cell research is whether it...

  • Induction of tissue-specific stem cells by reprogramming factors, and tissue-specific selection. Noguchi, H; Saitoh, I; Tsugata, T; Kataoka, H; Watanabe, M; Noguchi, Y // Cell Death & Differentiation;Jan2015, Vol. 22 Issue 1, p145 

    Although induced pluripotent stem (iPS) cells have significant implications for overcoming most of the ethical issues associated with embryonic stem (ES) cells, there are still several unresolved issues related to the use of iPS cells for clinical applications, such as teratoma formation. In...

  • Genetic and epigenetic stability of human pluripotent stem cells. Lund, Riikka J.; Närvä, Elisa; Lahesmaa, Riitta // Nature Reviews Genetics;Oct2012, Vol. 13 Issue 10, p732 

    Studies using high-resolution genome-wide approaches have recently reported that genomic and epigenomic alterations frequently accumulate in human pluripotent cells. Detailed characterization of these changes is crucial for understanding the impact of these alterations on self-renewal and...

  • Constraining the Pluripotent Fate of Human Embryonic Stem Cells for Tissue Engineering and Cell Therapy -- The Turning Point of Cell-Based Regenerative Medicine. Parsons, Xuejun H. // British Biotechnology Journal;Oct-Dec2013, Vol. 3 Issue 4, p424 

    To date, the lack of a clinically-suitable source of engraftable human stem/progenitor cells with adequate neurogenic potential has been the major setback in developing safe and effective cell-based therapies for regenerating the damaged or lost CNS structure and circuitry in a wide range of...

  • Screening of human pluripotent stem cells using CGH and FISH reveals low-grade mosaic aneuploidy and a recurrent amplification of chromosome 1q. Dekel-Naftali, Michal; Aviram-Goldring, Ayala; Litmanovitch, Talia; Shamash, Jana; Reznik-Wolf, Haike; Laevsky, Ilana; Amit, Michal; Itskovitz-Eldor, Joseph; Yung, Yuval; Hourvitz, Ariel; Schiff, Eyal; Rienstein, Shlomit // European Journal of Human Genetics;Dec2012, Vol. 20 Issue 12, p1248 

    Pluripotency and proliferative capacity of human embryonic stem cells (hESCs) make them a promising source for basic and applied research as well as in therapeutic medicine. The introduction of human induced pluripotent cells (hiPSCs) holds great promise for patient-tailored regenerative...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics